Thursday Nov 28
Recent Ruling Clarifies Patent Litigation Timing Under Biosimilars Act
The first judicial interpretation of the Biologics Price Competition and Innovation Act of 2009 has finally arrived.
Thursday Nov 28
The Washington Post
UCB Not for Sale as Billionaire Shareholder Awaits Rewards
UCB SA's biggest shareholder says the Belgian drugmaker isn't for sale, even as analysts say medicines for rheumatoid arthritis and epilepsy make the company an attractive takeover target.
Wed Nov 20, 2013
Sandoz v. Amgen: Interpretation of the Biosimilar Act Results in...
On November 11, 2013, the U.S. District Court for the Northern District of California in Sandoz, Inc. v.
Fri Nov 15, 2013
Northern District of California Interprets the Biosimilars Act and...
In the first instance of a district court interpreting the patent litigation provisions of the Biologics Price Competition and Innovation Act , Judge Maxine E. Chesney dismissed a declaratory judgment action by Sandoz relating to its biosimilar version of Enbrel .
Family tell of fear after burglary
A WIGAN family say they are living in fear after a burglary took place in their home while they were asleep upstairs.
Wed Nov 13, 2013
Self insurance for Wisconsin state employees on hold
A proposal to self-insure state employees is on hold, as the board overseeing the workers' benefits on Tuesday shifted attention to data about the cost and use of various health services.
Tue Nov 12, 2013
Family devastated by break-in
A GOLBORNE family say they are living in fear after a burglary at their home while they were asleep upstairs.